Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Altria is the dominant player in the U.S. cigarette market with its Marlboro brand of cigarettes. The company grows its earnings by increasing the price of cigarettes, counteracting volume declines.

This Tobacco Stock's Dividend Is Now Yielding 9%: Time to Buy?

Kinder Morgan

Ventas

There are already many pieces of the puzzle that point to volatile times ahead. Undoubtedly, volatility can be a trader's best friend, but for investors, volatility paints a completely different scenario.

3 Stocks to Buy Ahead of the Coming VIX Spike

Emerson Electric

Coca-Cola

Lockheed Martin

Shell PLC

AT&T

Walgreens

As the year began, institutional investors fled growth stocks to the relative safety of value stocks. In the second quarter, some of that money moved back to growth stocks.

7 Value Stocks That Should Be on Every Investor's Radar This Fall

AGNC Investment

Enbridge

PIMCO Dynamic Income Fund

Exxon Mobil

The stock market closed down this week, with the S&P falling more than expected to a 3-month low. The Dividend Harvesting Portfolio has shown consistent growth and profitability, with a 3.44% profit on invested capital. Dividend income from various investment baskets has increased, with equities generating the highest income at 39.83%.

Dividend Harvesting Portfolio Week 133: $13,300 Allocated, $1,154.34 In Projected Dividends

Truist Financial

Verizon

Investors love dividend stocks because they not only provide dependable income but also give investors a great opportunity for solid total return.

The 5 Highest Yielding S&P 500 Stocks Pay 7% and Higher Dividends and May Be the Best Buys for Q4

Annaly Capital

Dividend stocks have substantially outperformed publicly traded companies that don't offer a payout over the long term. Though investment risk and high yields tend to correlate, there are high-octane income stocks that can deliver sustainably high payouts.

Want $1,000 in Super-Safe Annual Dividend Income? Invest $10,375 Into the Following 3 Time-Tested, Ultra-High-Yield Stocks

Armada Hoffler Properties

Bank of Nova Scotia

Canadian Imperial Bank of Commerce

Dominion Energy

Innovative Industrial Properties

Janus Henderson Group

Jackson Financial

Medifast

NewLake Capital Partners, Inc.

Philip Morris

AT&T 5.35 % Notes 2017-01.11.66 Global

Dividend growth stocks can provide reliable cash flows and promote share price appreciation. With this piece, we are screening dividend stocks based on safety, growth, and consistency. September's top dividend growth stocks with high yields we are touching on include NewLake Capital Partners, Armada Hoffler Properties, Kinder Morgan, 3M, and Philip Morris International.

September's 5 Dividend Growth Stocks With 5.31%+ Yields

Altria has defied the odds for almost 60 years, steadily hiking its dividend in the process. Cannabis REIT Innovative Industrial Properties maintained its dividend amid struggles in the marijuana industry.

Don't Mind Some Risk? 2 Ultra-High-Yield Dividend Stocks to Get Your Hands On

Enterprise Products Partners

Western Union

Dividend stocks are the best way to build wealth, which is why you should look for ultra-high yield stocks. The asset managers at Hartford Funds looked at the benchmark S&P 500 going all the way back to 1930 and found there hasn't been a single decade where dividend stocks didn't produce positive returns.

3 Extraordinary Ultra-High Yield Stocks to Buy Hand Over Fist

Viatris

High-yielding stocks can give you extra cash to help offset the impact of inflation. Many stocks are yielding far higher than 4%, including Viatris, Verizon, and Altria.

Want to Collect $500 in Dividends Every Month? Invest $90,000 in These 3 Stocks

The stock market declined in week 132, with the S&P 500 falling by 1.06% and the Dow Jones declining by 1.64%. The highly anticipated CPI data will be released on September 13th, with expectations of higher inflation and lower unemployment. The Dividend Harvesting Portfolio continues to generate consistent dividend income and has seen positive performance for 11 consecutive weeks.

Dividend Harvesting Portfolio Week 132: $13,200 Allocated, $1,138.32 In Projected Dividends

Alliance Resource Partners

Energy Transfer LP Unit

Lincoln National

Starwood Property

The newest rage in investing, for many who are not chasing artificial intelligence stocks, has been going to the safest possible investments.

Why These 7 Stocks With Dependable Dividends as High as 14% Could Soar in 2024

Boston Scientific

We believe that Boston Scientific stock (NYSE: BSX) is a better pick over Altria stock (NYSE: MO), given its better prospects.

Is Boston Scientific A Better Pick Over Altria Stock?

Altria (MO) is positioned to keep benefiting from its smoke-free products and pricing strategy. Management targets nearly doubling its smoke-free net revenues to $5 billion by 2028.

Altria (MO) Is Marching Ahead of the Industry: Will This Stay?

Johnson & Johnson

Roku

Roku's stock price has fallen 83% from its peak in 2021. The rocket-powered growth stock trades at just 3.7 times sales, which is comparable to many sleepy value investments.

Here's My Top Growth Stock to Buy in 2023

BYD Co Ltd

Electronic Arts

Lithium Americas Corp

Sysco

Tencent Holdings Limited

Even with a relatively small sum, say $500, there are plenty of stocks to buy that can pave the way for a brighter financial future. Contrary to what many believe, you don't need a fortune to start investing, which is why we've compiled this list of stocks to buy with less than $500.

7 No-Brainer Stocks to Buy With $500 Right Now

Turning Point Brands

22nd Century Group

The Zacks Tobacco industry players battle concerns surrounding soft cigarette volumes and high input costs, while pricing power and smoke-free products aid. Philip Morris (PM), Altria Group (MO), Turning Point (TPB) and 22nd Century Group (XXII) look well-placed.

4 Tobacco Stocks Worth Watching Despite Industry Concerns

Stanley Black & Decker

Target

Federal Realty Investment Trust

Northwest Natural Gas

Dividend Kings are attractive for risk-averse income investors and many other investment strategies. They have sustained and sustainable dividend growth and a relatively high yield compared to the average S&P 500 company.

Dividend Kings With the Highest Yield: 6 High Yields in 5 Minutes

It yields nearly 9%, after all. But yield isn't everything, even with a large and profitable business.

It's Not Too Late to Capitalize on This Popular Stock's New Dividend Raise

The company has increased its dividend significantly over the years.

Why Are Passive Income Investors Talking About Altria Stock?

Altria Group is the 4th largest tobacco company in the world by revenue and has raised its dividend for 53 consecutive years. Altria's financial metrics for the past year show positive results, with EPS and FCF increasing in spite of a decrease in revenue of 3%. Analysts have a positive outlook on Altria's prospects, with consistent buy ratings and optimism about its future performance.

Altria: Does The Latest Dividend Increase Mean It's A Buy?

Citigroup

Conservative investors are partying like it is 1999, as money market rates are at 4.5% and certificates of deposits are above the 5% level.

7 Perfectly Priced ‘Strong Buy' Dividend Blue Chip Stocks Yielding Up to 9.2%

Altria is planning the transition to a new form of consumption.

Huge News for Altria Stock Investors

As I had anticipated, Altria Group stock recovery was rejected in May. The market denied further buyers' optimism as MO underperformed the S&P 500. The market seems to be pricing in substantial execution risks for Altria despite its improved adjusted EPS in Q2. Buyers aren't convinced that Altria could overcome its challenges convincingly. MO's best-in-class "A+" valuation hasn't been enough to convince buyers that it offers significant appeal, given the industry's secular decline.

Altria: The Market Is Right, It's Cheap For A Reason

News for Altria Stock (MO)